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ABSTRACT. PPARγ is known to be activated via exercise-associated transient increases 
in oxidative stress. However, the precise mechanism(s) triggering PPARγ activation in 
monocytes during/following exercise remain to be confirmed. Here, two cohorts of five 
healthy male individuals undertook exercise bouts (cycling; 70% 2OV& max; 45min) in the 
presence/absence of dietary antioxidant supplementation (vitamins C (1000mg/day) and E 
(400IU/day) for four weeks prior to exercise), and monocytic AMPK/PGC-1α/PPARγ 
signalling was investigated in samples obtained pre- and up to 24h post-exercise, while 
THP-1 cells were cultured as an in-vitro monocyte model. In THP-1 cells, AMPKα1 was 
phosphorylated within 1h of menadione (15µM)-triggered increases in [ROS]cyto, an effect 
which was followed by upregulation of PPARγ and several of its target genes (PGC-1α, 
LXRα, ABCA1; 24-72h), with these effects being blunted by co-administration of Vitamin 
C (62.5µM). Conversely, treatment with oxLDL (1µg/mL; 24-72h), but not non-oxidised 
LDL, upregulated the above PPARγ-regulated genes without affecting AMPKα1 
phosphorylation. In-vivo, dietary antioxidant supplementation (which is known to prevent 
exercise-triggered increases in oxLDL levels) blunted exercise-associated upregulation of 
the above PPARγ-regulated genes, but had no effect on exercise-associated transient 
[ROS]cyto increases, or on AMPK phosphorylation. These data suggest that exercise-
associated PPARγ signalling effects appear, at least in monocytes, to be mediated by 
increased generation of PPARγ ligands via oxidation of lipoproteins (following exercise-
associated transient increases in oxidative stress), rather than via [ROS]cyto–mediated 
AMPK activation. These findings may be of clinical relevance, as PPARγ activation in 
monocytes is associated with beneficial effects related to Type-2 Diabetes and its 
cardiovascular complications. 
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Introduction. 
Exercise is well recognised as a systemic oxidative stressor [1-5]. This has been 
attributed to reactive oxygen species (ROS) being released from contracting skeletal 
myocytes; for example, H2O2’s long half-life is known to permit its diffusion across 
the myocyte membrane and thence its transport to other regions of the body [1,2]. 
Direct measurement of extracellular concentrations of ROS has detected increases 
from ~10µM to ~25µM during exercise [5], while Jackson has stated that: “muscle is 
able to release ROS…these ROS are capable of leading to an increased systemic 
oxidation, including in non-contracting tissues” [1]. Because the magnitude of this 
exercise-associated increase in ROS is quite modest (~two-fold increases, culminating 
in peak intracellular ROS concentrations of ~100nM [6]), the effects of this increase 
are more likely to involve redox-sensitive signalling effects than oxidative damage 
[1]. Accordingly, changes in gene expression can be induced by ROS produced during 
muscular contractions [7], and the resulting effects can be of clinical significance.  
 
The ligand-activated nuclear receptor ‘Peroxisome Proliferator Activated Receptor-
gamma’ (PPARγ) and its associated transcriptional coactivator ‘PPARγ Coactivator-
1alpha’ (PGC-1α) comprise a signalling system that appears to be subject to 
activation via this route. Exercise leads to increased PPARγ activity [3,8], and 
increased PPARγ and PGC-1α expression [9,10], within skeletal muscle, while 
transcriptional mapping of the effects of exercise on skeletal muscle has shown that 
many PGC-1α/PPARγ–regulated genes were among the genes upregulated [11]. 
PPARγ and PGC-1α are regulators of the expression of numerous target genes (ie. 
genes bearing PPARγ Response Elements (PPREs), to which activated PPARγ can 
bind) involved in antioxidant defence, metabolism, cell differentiation and 
inflammation [12,13]. Therefore, synthetic agonists for PPARγ (eg. thiazolidinediones 
Page 3 of 38
http://mc.manuscriptcentral.com/gfrr
Free Radical Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer-Review Only
such as rosiglitazone [14]) have been widely used to elicit beneficial effects in the 
contexts of Type-2 Diabetes (T2D) and cardiovascular risk [15]. However, the linking 
of rosiglitazone to negative patient outcomes (ie. increased risk of myocardial 
infarction/death from cardiovascular causes [16-18]) has raised safety concerns and in 
the light of these concerns, prescription of rosiglitazone has fallen dramatically in 
recent years [19]. Therefore, alternative means of inducing beneficial PPARγ-
dependent effects without also causing such deleterious effects are urgently required. 
 
In line with the observation that the PPARγ/PGC-1α system responds to oxidative 
stress [20], Ristow et al reported that dietary supplementation with antioxidants 
prevented some of the systemic cardiovascular risk-lowering effects of physical 
exercise, with increased signalling via PPARγ/PGC-1α being seen after exercise only 
in the absence of antioxidants [21]. Similar findings were obtained using a range of 
different antioxidants in several other studies [22-26]; these findings were proposed to 
extend the concept of ‘hormesis’ (defined as: “repeated exposure to sublethal stress 
that cumulates in enhanced stress resistance and ultimately increased survival rates” 
[27]) to the field of exercise-triggered cell signalling [4]. Hence, whereas prolonged 
exposure to high levels of ROS brings about cell damage, repeated exercise-
associated transient increases in ROS may – via triggering of PPARγ/PGC-1α 
signalling – underpin adaptive signalling processes which ultimately prove to be 
beneficial to health [4,21]. 
 
However, the cellular aspects of the above studies were confined to skeletal myocytes, 
and to the beneficial consequences of exercise-induced signalling via PPARγ/PGC-1α 
within myocytes (e.g. mitochondrial biogenesis, antioxidant defence). Importantly, 
given the systemic nature of the impact of exercise, and the contribution of non-
muscle cells to the systemic response to exercise, there is a need to establish whether 
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exercise-associated cell signalling within non-muscle cell types is also prevented by 
dietary antioxidant supplementation. The current study focuses on the effects of 
exercise-associated oxidative stress on monocytes, as it is well-established that 
monocytes are an exercise-responsive cell-type (eg. they infiltrate into tissues in the 
24-48h following each exercise bout in order to regulate local inflammation and 
mediate tissue repair/remodelling [28]). Also, it should be noted that PPARγ is known 
to regulate inflammatory responses and atherogenesis via its actions within this cell 
type [20,29], and that activation of PPARγ within monocyte-macrophages has been 
shown to be crucial to the systemic insulin-sensitising/anti-hyperglycaemic actions of 
rosiglitazone [30]. Finally, because monocytes are relatively easily collected, 
exercise-associated signalling effects within monocytes may potentially be feasible 
for use as novel ‘biomarkers’ for systemic PPARγ-mediated exercise-linked benefits 
[31]. 
 
We have previously demonstrated that participation in exercise can affect 
PPARγ/PGC-1α-mediated signalling events within monocytes [32-35]. Participation 
in an 8-week low-intensity exercise programme induced upregulation of several 
PPARγ target genes in monocytes, and this was associated with altered serum lipid 
profiles (increased HDL-C; decreased total cholesterol, LDL-C and triglycerides), 
indicating that exercise had enhanced reverse cholesterol transport via its effects on 
PPARγ signalling within monocytes [32]. Similarly, participation in low-intensity 
exercise exerted systemic anti-inflammatory effects that were linked to priming of 
monocytes for differentiation into the alternative M2 macrophage phenotype [35].  
 
Importantly, however, these studies did not identify a precise mechanism for linking 
exercise with PPARγ activation in monocytes. Conflicting explanations have been put 
forward with regard to precisely how exercise-associated oxidative stress triggers 
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PPARγ signalling. Specifically, because exercise-associated oxidative stress oxidises 
circulating lipoproteins, and the resulting oxidised lipoprotein (oxLDL) particles 
contain distinct chemical species to those contained within non-oxidised LDL (e.g. 
modified fatty acids, which would be plausible candidates for roles as PPARγ ligands 
[19]), exercise may trigger PPARγ-mediated transcriptional responses via generation 
of oxLDL [32,36]. In support of this, our previous observation that serum from 
exercising participants elicits PPRE-luciferase reporter gene activation in an in vitro 
system [34] suggests that exercise may be associated with generation of blood-borne 
PPARγ ligands. Alternatively, monocytes can either take up exogenous reactive 
oxygen species (ROS), such as that generated by contracting muscle [1-2]), or can 
generate ROS endogenously via the actions of monocyte-expressed agents such as 
NADPH oxidase [33]. Because the exercise-activated intracellular kinase AMPK 
(which has been known to play an active signalling role within monocytes for over a 
decade [37]) can be activated by increased levels of cytoplasmic ROS ([ROS]cyto) 
[38], and because PGC-1α is a substrate for AMPK [39], it has been suggested that a 
ROS→AMPK→PGC-1α cascade may underpin exercise’s impact upon PPARγ-
regulated patterns of gene expression [40].  
 
Therefore, in the present study we aimed to test the hypotheses that exercise/oxidative 
stress-associated PPARγ-mediated signalling responses within monocytes may be 
triggered via either generation of exercise-associated blood-borne PPARγ ligands, 
and/or activation of an intracellular ROS→AMPK→PGC-1α→PPARγ signalling 
axis; and that such responses may be prevented (or at least blunted) by dietary 
antioxidant supplementation.  
 
Methods.  
All reagents were from Sigma-Aldrich Ltd (Poole, UK) unless stated otherwise.  
Page 6 of 38
http://mc.manuscriptcentral.com/gfrr
Free Radical Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer-Review Only
Participant recruitment and exercise procedures. Two cohorts of healthy active male 
individuals (Group A (Exercise-alone): n=5; age: 32±8years; height: 179±11cm; body 
mass: 80±11kg; Group B (Exercise+Antioxidants): n=5; age: 32±6years; height: 
175±7cm; body mass: 79±10kg) were recruited to participate in the exercise study. 
All participants completed informed consent forms, and ethical approval was granted 
by the Cardiff Metropolitan University School of Health Sciences Research Ethics 
Committee; thus the study conforms to the principles outlined in the Declaration of 
Helsinki. In accordance with Ristow et al. [21], participants in Group B undertook 
dietary supplementation in the form of vitamins C (1000 mg/day) and E (400 IU/day) 
for 4 weeks prior to the exercise intervention. Both cohorts fasted overnight before 
undertaking exercise; standardization of food intake and physical activity prior to 
exercise was achieved via use of health/activity questionnaires. Exercise procedures 
were performed on a Monark 824E cycle ergometer (Monark Exercise AB, Varberg, 
Sweden). Participants first performed an incremental cycling test to exhaustion; each 
stage of the test lasted 3min, and the required power output increased by 30W at every 
stage until volitional exhaustion. Once maximal oxygen consumption ( 2OV& max) had 
been established (Group A: 44±14ml/kg/min; Group B: 48±9ml/kg/min), the power 
output corresponding to 70% 2OV& max was calculated for each participant; this 
intensity was used in a subsequent single 45min bout of exercise. In all cases, heart 
rate was monitored throughout using a Polar S810 HR monitor (Polar Electro, Oy, 
Finland), 2OV&  was monitored using a Jaeger Oxycon Delta system (Erich Jaeger 
GMBH & Co., Hoechberg, Germany), and capillary blood samples were taken every 
15min using finger capillary samples for determination of blood lactate concentration 
using an Analox GM7 Microstat analyser (Analox Instruments, London, UK).  
 
Isolation of human peripheral mononuclear cells from whole blood. Blood samples 
from the antecubital vein were obtained via phlebotomy from each participant at 
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baseline (‘pre’), immediately following exercise (‘post’) and 1.5h, 3h and 24h after 
exercise. For isolation of peripheral blood mononuclear cells, 10ml of heparinised 
blood was diluted 1:1 in Roswell Park Memorial Institute cell culture medium 1640 
(RPMI), layered over 10ml of Histopaque-1077 Ficoll-Hypaque and centrifuged at 
400 X G for 20min. Mononuclear cell suspensions were carefully removed from the 
Ficoll-Hypaque interface, and washed four times (500 X G; 10min) in 0.4ml of Active 
Motif phosphate inhibitor solution and 7.6ml Phosphate-Buffered Saline (PBS), 
before being subjected to flow cytometry, or harvesting of protein or RNA extracts 
(see below). It should be noted that leukocyte vitamin C content does not alter during 
this extraction procedure [24]. 
 
Maintenance of cells in culture. Cells from the monocytic THP-1 cell line ([39]; 
obtained from ATCC (Teddington, UK)) were allowed to grow and propagate under 
controlled conditions (37
o
C; in a humidified 5% CO2 atmosphere) in RPMI 
supplemented with 1% v/v penicillin/streptomycin, 10% v/v fetal calf serum, 1% 
v/v non-essential amino acids, 1% L-glutamine and 1% v/v sodium pyruvate. Cells 
were seeded at ~0.3x10
6
 cells/ml and passaged at ~1x10
6 
cells/ml after a growth 
period of 3-4 days. Experiments were routinely performed with cells at passage <25, 
and at viability >95% as measured by trypan blue exclusion. Samples (5x10
6 
cells) 
were incubated with the macrolide antibiotic oligomycin (a mitochondrial ATP 
synthase inhibitor; 1µM), the H2O2 donor menadione (15µM), the antioxidant 
vitamin C (62.5µM), commercially available preparations of oxidized low-density 
lipoprotein (oxLDL) and non-oxidised low-density lipoprotein (LDL) (Autogen 
Bioclear Ltd [Nottingham, UK]; 1µg/mL in both cases – this corresponds 
approximately to serum oxLDL levels seen in sedentary individuals in our previous 
studies [32]); and 13-hydroxyoctadecadienoic acid (13-HODE; 5µM) at 37°C for 
the indicated times. 
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Flow cytometric measurements of [ROS]cyto. [ROS]cyto quantitation was achieved by 
following (with minor  modifications) the method of Hirpara et al [42], which utilised 
dichlorodihydrofluorescin diacetate (H2DCFDA) as an indicator sensitive to a number 
of ROS including H2O2, superoxide, nitric oxide and peroxynitrite [1]. THP-1 cells 
treated for 1h with menadione (15µM) ± vitamin C (62.5µM), or mononuclear cell 
samples from the cycling cohort, were subjected to flow cytometric analysis. In the 
latter case, leukocytes (extracted from whole blood via incubation for 10 min with 
Optilyse C Lysis Solution (Beckman Coulter, Buckinghamshire, UK) to lyse 
erythrocytes) were centrifuged (5min; 300 X G), washed and resuspended in PBS at a 
concentration of 10
5
cells/ml. 100µL cell aliquots of THP-1 cells, or leukocytes taken 
pre- and up to 24h post-exercise, were loaded with H2DCFDA (Molecular Probes, 
Eugene, OR, USA; 2.5µM; 10min; 4
o
C), washed, and the resulting fluorescence (λex 
= 495nm; λem=524nm) analysed using a Beckman FACS FC500 flow cytometer 
(Becton Dickinson, Mountain View, CA, USA). [ROS]cyto values were compared for 
samples taken ‘pre’ and ‘post’ exercise, and for treated versus control THP-1 samples. 
Separate electronic ‘gates’ were set with regard to forward and side scatter to 
differentiate between different subpopulations of leukocytes, and thus to specifically 
quantitate [ROS]cyto, within monocytes.  
 
Western blot analysis. Western blot experiments were carried out as described 
previously [33]. Briefly, total protein extracts from THP-1 cells, or mononuclear cell 
samples from the cycling cohort, were prepared by treatment with 100µl of Protein 
Extraction/Lysis buffer, containing 1mM Protease inhibitor cocktail and 1mg/ml 
phosphatase inhibitor (Active Motif Ltd, Rixensart, Belgium). Protein content was 
then estimated using a Bio-Rad protein assay (Bio-Rad Laboratories, Basingstoke, 
UK). Samples (50µg protein) were subjected to SDS-PAGE, transferred to 
nitrocellulose membranes and probed with primary antibodies (16h), followed by 
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HRP-labelled anti-rabbit IgG antibody (2h; 1:2000 dilution; Cell Signalling Tech., 
Danvers, MA, USA). Immunogenic bands were detected via enhanced 
chemiluminescence (West Pico Dura Luminol/enhancer substrate, Rockford, lL, 
USA). using a UVP Bioimaging AutoChemi system (UVP, Cambridge UK). The 
following primary antibodies were used: anti-phospho-AMPK (threonine residue 172) 
(1:1000; Cell Signalling Tech., Danvers, MA, USA); anti-AMPKα1 (1:1000; Cell 
Signalling Tech., Danvers, MA, USA); anti-PGC-1α (1:1000; Cell Signalling Tech., 
Danvers, MA, USA). Anti-β-actin antibodies (1:1000; Cell Signalling Tech., Danvers, 
MA, USA) were used for normalisation purposes, in order to confirm equal loading of 
samples. Activation of AMPK was expressed as the ratio of phosphorylated to total 
AMPKα1, as detected as 63KDa immunogenic bands on Western blots using 
antibodies directed against and total AMPKα1 respectively. PGC-1α was detected as 
~115KDa and ~105KDa immunogenic bands on western blots. Specificity of 
immunoreactivity in anti-PGC-1α Western blots was confirmed using addition of a 
PGC-1α blocking peptide to the primary antibody incubation step (5-fold excess by 
weight of peptide:IgG; Autogen Bioclear Ltd, Wiltshire, UK).   
 
Isolation of RNA and RT-PCR assays. The extraction of total RNA was carried out 
using a RiboPure-Blood Kit (Ambion®, Huntingdon, UK) according to 
manufacturers’ instructions. Briefly, 5x10
6 
THP-1 or mononuclear cells were washed 
in ice-cold PBS, lysed and RNA extracted using acid phenol-chloroform extraction, 
ethanol precipitation, and resuspension in RNAase-free water. RNA was quantified 
and checked for purity using the ratio of its absorbance at 260:280nm (only samples 
of ratio>1.8 being deemed suitable for use). RNA samples were stored at -80ºC before 
conversion to cDNA using an Applied Biosystems® High-Capacity cDNA Archive 
Kit (Applied Biosystems, Warrington, UK) and storage at –20°C. LXRα, ABCA1, 
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PPARγ and PGC-1α mRNA expression were analysed using Fast SYBR Green 
Master Mix (Applied Biosystems, Warrington, UK), and compared with that of 
Glyceraldehyde Phosphate Dehydrogenase (GAPDH). Importantly, preliminary 
experiments showed that mRNA expression for these genes was significantly enriched 
(2.5- to 6-fold) in purified monocytes (obtained using commercial QuadroMACS 
separator units, LS columns and CD14 MicroBeads (Miltenyi Biotec, Bisley, UK) 
according to the manufacturers’ instructions) compared with in mixed mononuclear 
cell samples [data not shown], indicating that the cDNA species detected in our RT-
PCR experiments are derived from monocyte subsets within the original mononuclear 
cell samples. Primers with the following sequences were designed using Primer 
Express ® software V 2.0 (Applied Biosystems, Warrington, UK): LXRα: 5’-
CGCACTACATCTGCCACAGT-3’ 5’- TGAGGCGGATCTGTTCTTCT-3’; PGC-1α: 5’-
TCAGTCCTCACTGGTGGACA-3’ 5’-TGCTTCGTCGTCAAAAACAG-3’; ABCA1: 5’-
GCACTGAGGAAGATGCTGAAA-3’, 5’-AGTTCCTGGAAGGTCTTGTTCA-3’; PPARγ: 5’- 
CGTGGCCGCAGATTTGAA-3’, 5’- CTTCCATTACGGAGAGATCCAC-3’; GAPDH: 5’-
TCCTGTGGCATCCACGAA-3’ 5’-GAAGCATTTGCGGTGGAC-3’. Thermocycling was as 
follows: initial denaturation for 10min at 95
o
C, followed by 40 cycles of 15sec at 
95
o
C/60sec at 60
o
C. Relative quantification of target genes was calculated using the 2
-
∆∆CT formula, in which ∆CT equals the difference between CT (cycle threshold) values 
for gene-of-interest and housekeeping gene.  
 
Statistical methods. Data are expressed as mean±standard deviation. Multiple 
between-group and within-group comparisons were performed using two-way or one-
way analysis of variance (ANOVA) respectively, with post-hoc analysis performed 
using Tukey’s method in each case. For non-multiple comparisons, 2-sample t-tests 
were used. Significance levels were set at P<0.05 (P<0.10 was referred to as 
‘borderline-significant’). 
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Results. 
In-vitro studies (i.e. THP-1 experiments). We aimed to mimic exercise-induced 
increases in [ROS]cyto by treating THP-1 cells with the H2O2 donor menadione, and 
also used the mitochondrial ATP synthase inhibitor oligomycin as a positive control 
for AMPK activation. The properties of both reagents were confirmed in our 
experiments: menadione treatment (15µM; 1h) led to significant increases in 
[ROS]cyto within THP-1 cells (355.8±43.4% basal; P<0.05 [1-way ANOVA]; Fig 1A), 
while 1µM oligomycin induced a significant decrease in THP-1 intracellular ATP 
content within 10min (62.9±6.0% basal; P<0.05 [1-way ANOVA]; data not shown). 
Moreover, menadione-induced increases in [ROS]cyto were significantly blunted by 
co-administration with Vitamin C (62.5µM; P<0.05 [2-way ANOVA]; Fig 1A).  
 
As AMPK can be activated by both cellular energy depletion [43] and increased 
[ROS]cyto [38], we next investigated the effects of oligomycin and menadione on 
activation of AMPKα1, as represented densitometrically by the ratio of 
phosphorylated to total AMPKα1 within total protein extracts from THP-1 cells. 
Oligomycin treatment led to approximately two-fold AMPKα1 activation (5 min; 
208.7±46.4% basal; P<0.05 [2-sample t-test]; Figs 1B and 1C), while menadione was 
associated with approximately three-fold AMPK activation (1h; 346.8±16.3% basal; 
P<0.05 [2-sample t-test]; Figs 1B and 1C). Once again, menadione-induced effects 
were significantly blunted by co-administration with Vitamin C (P<0.05 [2-way 
ANOVA]; Figs 1B and 1C). We also treated THP-1 cells with oxLDL (1-72h; 
1µg/mL), but this reagent did not significantly increase AMPK phosphorylation 
(P>0.05 [2-sample t-test]; Figs 1B and 1C). 
 
Jäger et al have reported that PGC-1α is a substrate of AMPK in skeletal muscle [39]; 
therefore, we carried out further Western blot experiments to investigate PGC-1α in 
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THP-1 cells. As shown in Fig 2, a doublet of immunogenic bands of molecular 
weights ~105 and ~115KDa was detected on anti-PGC-1α western blots, with both 
bands being competed out by addition of a PGC-1α blocking peptide to the primary 
antibody incubation step (5-fold excess by weight of peptide:IgG (i.e. ~1µg/ml)). 
After 1h treatment with oligomycin or menadione, the larger molecular weight form 
pre-dominated (115KDa band:doublet ratios: 0.38±0.03 (control); 0.85±0.05 
(oligomycin; P<0.05 [2-sample t-test]); 0.63±0.06 (menadione; P<0.05 [2-sample t-
test]). Co-administration with vitamin C appeared to blunt menadione’s effect, albeit 
without attaining statistical significance (115KDa band:doublet ratio: 0.53±0.04; 
P>0.05 [2-way ANOVA]), while neither oxLDL (0.32±0.06; P>0.05 [2-sample t-
test]) nor LDL (0.36±0.11; P>0.05 [2-sample t-test]) affected the respective levels of 
the two bands within the doublet. Because post-translational modifications such as 
phosphorylation reduce substrate proteins’ electrophoretic mobility, this may indicate 
that activated AMPKα1 phosphorylates PGC-1α in oligomycin- or menadione-treated 
THP-1 cells.  
 
Given that phosphorylation of PGC-1α leads to its activation as a transcriptional co-
activator [39], we next investigated the effects of the above treatments on the 
expression of PPARγ/PGC-1α target genes. These include LXRα (whose upregulation 
leads to consequent upregulation of the LXRα target gene ABCA1), and also the 
PPARγ and PGC-1α genes themselves (whose promoters contain PPARγ response 
elements) [32,35,44,45]. In these genes, mRNA expression was increased by 1.5-4-
fold following 24h treatment with oligomycin (Fig 3; P<0.05 [1-way ANOVA] where 
indicated), but returned approximately to basal levels within 72h (in contrast, mRNA 
expression of the AMPKα1 gene was unchanged throughout 72h of oligomycin 
treatment (data not shown)). Treatment with menadione induced highly significant 
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increases in gene expression of PGC-1α and PPARγ (Fig 3; P<0.01 [1-way 
ANOVA]), and borderline-significant increases in gene expression of LXRα and 
ABCA1 (P<0.10 [1-way ANOVA]), while direct comparison of menadione versus 
menadione-plus-vitamin-C showed significant  blunting of menadione’s effects by co-
administration with vitamin C in 3 out of the 4 genes (ABCA1, PPARγ - P<0.01;  
LXRα - P<0.05 [2-way ANOVA]).  
 
Interestingly, although oxLDL did not induce phosphorylation of either AMPKα1 or 
PGC-1α (see Figs 1 and 2), mRNA expression of PGC-1α and LXRα appeared to 
increase in oxLDL-treated samples (Figs 4A and 4B), either significantly as compared 
to non-oxidised LDL (P<0.05 [2-way ANOVA]: LXRα), or non-significantly (P>0.05 
[2-way ANOVA]: PGC-1α). As 13-HODE has previously been identified as both a 
breakdown product of oxLDL and a PPARγ ligand [34,36], THP-1 cells were treated 
with 13-HODE (5µM; 24h) in an additional experiment. As shown in Fig 4C, 
expression of PGC-1α and LXRα underwent significant 2-4-fold increases (PGC-1α - 
P<0.01; LXRα - P<0.05 [1-way ANOVA]) following 13-HODE treatment. Finally, 
given the lack of statistical significance seen for PGC-1α mRNA expression in the 
RT-PCR experiment shown in Fig 4A, total PGC-1α protein expression (ie. 
expression of both bands within the above doublet on Western blots; β-actin was used 
for normalisation purposes, in order to confirm equal loading of samples) was 
assessed: as shown in Figs 4D and 4E, PGC-1α underwent significant increases 
following 48h treatment with menadione (P<0.05 as compared to menadione-plus-
vitamin-C [2-way ANOVA]), or with oxLDL (P<0.05 as compared to non-oxidised 
LDL [2-way ANOVA]). 
 
In-vivo studies (i.e. samples obtained from exercising participants). The exercise 
intervention used was similar to that utilised in our previous studies [33], with the 
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exception that two comparable cohorts were recruited, one of which undertook dietary 
antioxidant supplementation for 4 weeks before undertaking exercise (Group B), 
while the other did not (Group A). The physiological stresses resulting from the bouts 
of exercise, as indicated by mean heart rate, blood lactate concentration and 2OV& , 
were not significantly different between the two cohorts (data not shown), indicating 
that exercise was performed at a comparable intensity in all cases.  
 
Analysis via H2DCFDA fluorescence-mediated flow cytometry of monocytes 
obtained from exercising participants indicated that transient, ~2-fold increases in 
[ROS]cyto were seen in monocytes within 3h of cessation of exercise (see Fig 5A). 
Importantly, this effect was evident in both Group A (pre: 65.0±12.0µM; 3h: 
122.8±39.9µM; P<0.05 [1-way ANOVA]), and Group B (pre:  46.9±15.0nM; 3h: 
113.7±11.0nM; P<0.05 [1-way ANOVA]), while direct comparison of the two groups 
showed no significant differences between their [ROS]cyto responses before, during or 
after exercise (P>0.05 [2-way ANOVA]). These values are in line with data obtained 
using a similar approach in isolated mouse muscle fibres, when baseline and post-
exercise intracellular ROS concentrations of ~10-100nM and 100-200nM, 
respectively, were obtained [6]. Similarly, as shown in Fig 5B, no differences in 
AMPK phosphorylation (measured pre- and 3h post-exercise) were seen between 
Groups A and B (P>0.05 [2-sample t-test] in both cases).  
 
Importantly, as shown in Fig 6, despite there being no inter-group differences with 
regard to [ROS]cyto or AMPK, significant (or borderline-significant) increases in 
expression of PPARγ/PGC-1α-regulated genes were observed in samples taken from 
Group A within 3h of exercise (PPARγ and PGC-1α (P<0.05 [1-way ANOVA]); 
LXRα and ABCA1 (P<0.10 [1-way ANOVA])). Importantly, such increases were not 
seen in Group B; direct comparison of the two groups showed significant antioxidant-
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associated blunting of the response to exercise with regard to expression of PPARγ 
(P<0.01 [2-way ANOVA]) and PGC-1α (P<0.05 [2-way ANOVA]).  
 
Discussion.  
In the current study, we present data which support the view that exercise is an 
oxidative stressor (reviewed in [1,2,5]), and elucidate several downstream 
consequences of exercise-induced oxidative stress with regard to monocyte cell 
signalling.  
 
As previously stated, there is a need to establish whether the exercise-associated cell 
signalling effects demonstrated in skeletal myocytes by Ristow et al [21] also occur in 
non-muscle cell types such as monocytes. ROS are able to act as autocrine factors that 
trigger cell signalling responses [2,7,46]; however, increased ROS generation by 
mitochondria during exercise is unlikely to be the case in monocytes, as vascular cells 
are dependent primarily on glycolysis for their energetic demands [37,47], and so 
monocytes would not be expected to generate large amounts of mitochondrial ROS. 
Moreover, we have previously shown that monocytic expression of the NADPH 
oxidase catalytic subunit NOX2 decreased after exercise [33], which indicates that 
NADPH-catalysed endogenous generation of ROS is unlikely to increase following 
exercise. Instead, paracrine/endocrine actions of skeletal muscle-derived ROS (ie. 
diffusion of ROS from contracting myocytes into the external milieu, and possibly 
into the circulation [1,2]) are likely to be responsible for exercise-triggered signalling 
responses within monocytes. This suggestion is supported by our previous 
observation that exercise is associated with decreased GSH in the serum [33,34]. 
Once in the circulation, muscle-derived ROS may either oxidise circulating 
macromolecules such as lipoprotein particles (as supported by our previous 
observation that exercise is associated with transient increases in serum oxLDL [32]), 
Page 16 of 38
http://mc.manuscriptcentral.com/gfrr
Free Radical Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer-Review Only
and/or may diffuse into circulating cells such as monocytes. The present study 
attempted to establish which of these two possibilities is the source of the exercise-
triggered monocyte signalling responses seen previously [32-35]. 
 
As previous in-vitro studies have shown that exposure of cultured myotubes to pro-
oxidants induces signalling responses involving upregulation of numerous genes, 
including PGC-1α [7,40], we initially investigated the responses of cultured THP-1 
monocytic cells to menadione (a cell-permeable H2O2 donor) or oxLDL (a blood-
borne marker of oxidative stress). We found that responses were prevented (or at least 
significantly blunted) if menadione was co-administered alongside vitamin C, or if 
cells were treated with non-oxidised LDL rather than oxLDL. Hence, in both cases, it 
seems plausible to conclude that oxidative stress is the ‘trigger’ for these responses, 
and therefore that these in-vitro experiments are acceptable models for the exercise-
associated oxidative stress seen in-vivo. Figs 1-3 show that AMPKα1 was 
phosphorylated within 1h of menadione-triggered increases in [ROS]cyto, and that this 
appeared to be followed by phosphorylation of PGC-1α, and upregulation of several 
PPARγ/PGC-1α target genes, with these effects being blunted by co-administration of 
vitamin C alongside menadione. Conversely, while Fig 4 shows that oxLDL – but not 
LDL – upregulates several PPARγ/PGC-1α target genes, Figs 1 and 2 suggest that this 
effect occurred without phosphorylation of either AMPKα1 or PGC-1α. Given the 
data in Fig 4C, and the previous demonstrations by ourselves and others that the 
oxLDL component 13-HODE is a PPARγ ligand [34,36], it seems likely that ligand-
dependent PPARγ activation is responsible for the upregulation of PPARγ/PGC-1α 
target genes in these oxLDL experiments.  
 
Thus, we concluded that both [ROS]cyto-triggered upstream kinase cascades and direct 
provision of ligands are capable of activating PPARγ signalling in our in-vitro model 
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system. We next carried out an in-vivo series of experiments that aimed to elucidate 
which of these possibilities is responsible for the observed effect of exercise in 
activating PPARγ signalling within monocytes, and also whether dietary antioxidant 
supplementation could block these effects.  
 
Although there was some variability within the dataset shown in Fig 6, PPARγ/PGC-
1α target gene expression broadly increased following exercise, with these exercise-
associated gene expression effects being blunted by dietary antioxidant 
supplementation. However, while Fig 5A showed that [ROS]cyto increased post-
exercise, this effect occurred to similar extents in both the exercise-alone or exercise-
plus-antioxidants groups, and furthermore no differences in AMPKα1 activation 
status could be detected between the two groups (see Fig 5B). Therefore, it is unlikely 
that [ROS]cyto-mediated AMPK phosphorylation could be responsible for the 
exercise-associated activation of PPARγ signalling observed in the RT-PCR data 
obtained from the exercise-alone group, or that an effect of antioxidants on [ROS]cyto–
mediated AMPK activation could be responsible for the ‘blunting’ effects seen in the 
comparable data from the exercise-plus-antioxidants group. Rather, it seems that, 
although exercise-associated increases in [ROS]cyto do occur, unlike menadione-
induced in-vitro oxidative stress (whose impact involved larger increases in 
[ROS]cyto), these increases apparently do not couple with downstream PPARγ 
signalling effects in-vivo.  
 
Conversely, antioxidant supplementation is known to prevent increases in oxidation 
of extracellular [ie. serum/plasma] lipids/lipoproteins, in the contexts of both 
pharmacologically-induced oxidative stress [48] and exercise [21,49] (as measured by 
GC-MS and TBARS assays, respectively). Therefore, given the differential effects 
seen for oxLDL versus non-oxidised LDL treatments in Fig 4, the ‘blunting’ effects 
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seen in Fig 6 suggest that antioxidant-preventable exercise-associated monocytic 
PPARγ signalling may be mediated by increased generation of blood-borne PPARγ 
ligands via oxidation of lipoproteins (following exercise-associated transient increases 
in oxidative stress), rather than via [ROS]cyto–mediated AMPK activation. 
 
Exercise-related signalling events in monocytes have not been as intensively studied 
as those in skeletal muscle, and to our knowledge this study is novel in that it provides 
evidence extending previous observations concerning the ability of antioxidants to 
block exercise-triggered skeletal myocyte signalling responses [21-26] to an 
additional cell type, namely the monocyte. In a broader sense, the findings of the 
present study support the view that exercise is a systemic phenomenon whose impact 
is not limited to skeletal muscle. It should be acknowledged that several differences 
exist between the respective exercise-triggered pathways in muscle and monocytes, 
most notably that PPARγ controls expression of different genes, and so exerts 
different effects, in monocytes and muscle [11,32]. Nevertheless, PPARγ signalling is 
involved in regulation and integration of inflammation and lipid metabolism 
throughout the whole body, with PPARγ carrying out distinct but complementary 
functions in diverse tissues [20].  For example, exercise-triggered PPARγ signalling is 
involved in both the regulation of adipocyte triglyceride hydrolysis/esterification 
processes so as to boost release of fatty acids into the bloodstream [50], and the 
increased expression of skeletal muscle genes linked to oxidative metabolism of fats 
[10]. Thus, although different genes are activated in different tissues, a 
complementary array of effects is induced, and the systemic impact is broadly 
beneficial in the context of T2D. Our study’s identification of monocytes as an 
exercise-responsive cell-type, in which PPARγ can be activated to upregulate 
beneficial anti-oxidant/anti-inflammatory/lipid-handling genes [30,32-36,44], is in 
line with this concept. 
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The current study has several limitations, including the small cohort size (with the 
accompanying variability in the data obtained), and the fact that participants were 
followed up for only 24h after a single bout of exercise (rather than more prolonged 
exercise programmes being investigated). With regard to follow-up, it should be noted 
that targets of PPARγ/PGC-1α have longer half-lives at the protein – and therefore the 
functional – level, than at the mRNA level. Thus, although mRNA expression had 
declined by 24h after each exercise bout, effects on monocyte function are likely to 
persist for longer than 24h after each exercise bout. Importantly, the PPARγ/PGC-1α 
signalling effects seen here were similar – but less pronounced – to those seen 
previously in 8-week exercise programmes (>3-fold increases [32-35]); thus, it is 
possible that the effects of each individual exercise bout may accumulate, so that after 
an extended programme of regular exercise larger, sustained effects are evident. 
Another limitation is the lack of direct measurement of the impact of antioxidant 
supplementation on blood-borne oxLDL levels; however, it should be noted that 
several previous studies have shown that antioxidant supplementation prevents 
exercise-induced increases in oxidised lipids/lipoproteins [21,49], and so we feel 
justified in tentatively linking the observed blunting of exercise-induced upregulation 
of the above PPARγ/PGC-1α target genes to prevention of oxLDL generation in our 
exercise-plus-antioxidant cohort.  
 
In conclusion, exercise-associated activation of monocytic PPARγ signalling, and 
blunting of this response in participants undertaking dietary antioxidant signalling 
alongside exercise, were seen in the current study. It should be noted that, while 
parameters relevant to cardiovascular risk such as blood lipids and insulin sensitivity 
were not directly measured in this study (which was designed to be primarily 
mechanistic in nature), our previous exercise studies have demonstrated that enhanced 
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monocytic PPARγ/PGC-1α target gene expression positively correlates with increased 
HDL-C [32], and also with improved insulin sensitivity [Ruffino, personal 
communication]. Also, although the current study involved healthy participants, it 
should be noted that individuals with T2D exhibit decreased PGC-1α [51] and PPARγ 
[52]. Therefore, if individuals with T2D were to respond in a similar manner to the 
participants in the current study – and T2D and non-T2D cohorts have been shown to 
respond in a similar manner to exercise [3,53] – it is possible that the exercise-
associated effects seen here could help normalise PGC-1α/PPARγ signalling in T2D. 
Thus, novel signalling effects that are linked to exercise-associated transient increases 
in oxidative stress have been reported in the current study, and these may be 
associated with cardiovascular risk-lowering effects associated with upregulation of 
insulin-sensitising and/or lipid-handling genes within monocyte/macrophages, and so 
could potentially contribute to both the prevention of development of T2D in healthy 
or pre-diabetic individuals, and the normalisation of aberrant metabolic function in 
individuals with T2D.  
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Figure Legends. 
Fig 1: The Effect of Oligomycin, Menadione±Vitamin C or oxidised LDL on 
THP-1 AMPKα1 phosphorylation. THP-1 cells were treated for 1h with either 
oligomycin (1µM; black bar), menadione (15µM; dark grey bar), menadione plus 
vitamin C (15µM and 62.5µM; medium grey bar), or oxidised LDL (1µg/mL; light 
grey bar), before either being subjected to loading with the ROS-sensitive dye 
H2DCFDA and determination of [ROS]cyto using flow cytometry (A), or harvesting of 
total protein extracts, and subjecting to Western Blotting using anti-AMPKα1 
(1:1000) or anti-p-AMPK (1:500) 1
o
 antibodies ((B): Representative images; (C): 
densitometric data (ie. phosphorylated AMPK:total AMPKα1) summarised in 
graphical form  (n>3; * P<0.05)). 
Fig 2: The Effect of Oligomycin or Menadione±Vitamin C on THP-1 expression 
of different forms of PGC-1α. THP-1 cells were treated for 1h with either 
oligomycin (1µM; black bars), menadione (15µM; dark grey bar), menadione plus 
vitamin C (15µM and 62.5µM; medium grey bar), oxidised LDL (1µg/mL; light grey 
bar), or non-oxidised LDL (1µg/mL; white bar) before harvesting of total protein 
extracts, and subjecting to Western Blotting using anti-PGC-1α (1:500) 1
o
 antibodies. 
(A): Representative images; (B): densitometric data (ie. 115KDa band:total PGC-1α 
doublet) summarised in graphical form  (n>3; * P<0.05). 
Fig 3: The Effect of Oligomycin or Menadione±Vitamin C on PGC-1α/PPARγ 
Target Gene Expression. THP-1 cells were treated for up to 72h with either 
oligomycin (1µM; dark grey bars), menadione (15µM; medium grey bars), or 
menadione plus vitamin C (15µM and 62.5µM; white bars), before harvesting of total 
RNA samples and determination of mononuclear cell PGC-1α (A), PPARγ (B), 
LXRα (C), and ABCA1 (D) mRNA levels, as carried out via SYBR Green RT-PCR  
(n>3; ** P<0.01; * P<0.05; 
(
*
)
 P<0.10). 
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Fig 4: The Effect of oxidised LDL, non-oxidised LDL or 13-HODE on PGC-
1α/LXRα Expression. THP-1 cells were treated for up to 72h with either non-
oxidised LDL (1µg/mL; white bars in (A)/(B)), oxidised LDL (1µg/mL; grey bars in 
(A)/(B)), or 13-HODE (5µM; all bars in (C)), before harvesting of total RNA samples 
and semi-quantitative determination of mononuclear cell PGC-1α (A, C) and LXRα 
(B, C) mRNA levels, as carried out via SYBR Green. Also, THP-1 cells were treated 
for 48h with either menadione (15µM; dark grey bars), menadione plus vitamin C 
(15µM and 62.5µM; medium grey bars), oxidised LDL (1µg/mL; light grey bars), or 
non-oxidised LDL (1µg/mL; white bars) before harvesting of total protein extracts, 
and subjecting to Western Blotting using anti-PGC-1α (1:500) or anti-β-actin (1:2000) 
1
o
 antibodies. (D): Representative images; (E): densitometric data (ie. 115KDa 
band:total doublet, normalised to β-actin in each case) summarised in graphical form 
(n>3 in all cases; ** P<0.01; * P<0.05). 
Fig 5: The Effect of Exercise on Intracellular ROS Levels, and on AMPK 
activation in Peripheral Mononuclear Cells. Samples were obtained from 2 cohorts 
of exercising participants (exercise alone (white bars); exercise plus antioxidants 
(vitamins C (1000mg/day) and E (400IU/day) for four weeks prior to exercise; grey 
bars); 45min of cycling at 70% max in both cases). (A): Mononuclear cells were loaded 
with the ROS-sensitive dye H2DCFDA and monocyte [ROS]cyto determined using 
flow cytometry for samples taken pre, post, 1.5h , 3h and 24h  following exercise. (B): 
Total protein extracts were harvested and subjected to Western Blotting using anti-
AMPKα1 (1:1000) or anti-p-AMPK (1:500) 1
o
 antibodies. Representative images of 
phosphorylated AMPK:total AMPKα1 are shown for samples taken pre and 3h-post 
exercise (n=5 in each case; * P<0.05).  
Fig. 6: The Effect of Exercise on PGC-1α/PPARγ Target Gene expression in 
Peripheral Mononuclear Cells. Peripheral mononuclear cell samples were obtained 
from 2 cohorts of exercising participants (exercise alone (white bars); exercise plus 
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antioxidants (vitamins C (1000mg/day) and E (400IU/day) for four weeks prior to 
exercise; grey bars); 45min of cycling at 70% max in both cases). Total RNA samples 
were harvested, and semi-quantitative determination of mononuclear cell PGC-1α 
(A), PPARγ (B), LXRα (C) and ABCA1 (D) mRNA levels was carried out using RT-
PCR for samples taken pre-exercise, and 3h and 24h following exercise (n=5 in each 
case; ** P<0.01;* P<0.05; 
(
*
)
 P<0.10). 
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